Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue EstimatesZacks Investment Research • 11/06/25
Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate UpdateGlobeNewsWire • 11/06/25
Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025GlobeNewsWire • 10/30/25
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical CompanyGlobeNewsWire • 10/29/25
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. MarketGlobeNewsWire • 10/28/25
Lifecore Biomedical to Participate at Upcoming Industry Conferences and EventsGlobeNewsWire • 10/13/25
LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 09/27/25
Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 09/26/25
Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock?Zacks Investment Research • 09/12/25
Lifecore Biomedical, Inc. (LFCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing ConferenceGlobeNewsWire • 09/04/25
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 08/15/25
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 08/08/25
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/07/25
Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025GlobeNewsWire • 07/31/25
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to ConnectAccesswire • 06/17/25
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing CustomerGlobeNewsWire • 06/17/25
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire • 06/15/25
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the InvestigationAccesswire • 06/12/25
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment SaleGlobeNewsWire • 06/12/25
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities InvestigationAccesswire • 06/10/25